Jie Jin

Active 1997–2026

514
Papers
28,684
Citations
82
h-index
394
i10-index

Citations

Citations per year for Jie Jin1956: 1 citations1979: 1 citations1986: 1 citations1994: 1 citations1998: 10 citations1999: 6 citations2000: 5 citations2001: 7 citations2002: 5 citations2003: 5 citations2004: 3 citations2005: 12 citations2006: 22 citations2007: 21 citations2008: 45 citations2009: 75 citations2010: 79 citations2011: 94 citations2012: 119 citations2013: 118 citations2014: 159 citations2015: 128 citations2016: 145 citations2017: 177 citations2018: 264 citations2019: 760 citations2020: 1,067 citations2021: 1,195 citations2022: 1,189 citations2023: 1,044 citations2024: 1,855 citations2025: 1,253 citations2026: 289 citations2027: 1 citations1957–1978: no citations, so these years are not shown1980–1985: no citations, so these years are not shown1987–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,298 citing papers, 32.9% of this breakdownUnited States: 2,202 citing papers, 16.9% of this breakdownUnited Kingdom: 547 citing papers, 4.2% of this breakdownItaly: 491 citing papers, 3.8% of this breakdownGermany: 440 citing papers, 3.4% of this breakdownFrance: 328 citing papers, 2.5% of this breakdownIndia: 324 citing papers, 2.5% of this breakdownCanada: 310 citing papers, 2.4% of this breakdownAustralia: 280 citing papers, 2.1% of this breakdownSouth Korea: 274 citing papers, 2.1% of this breakdownSpain: 254 citing papers, 1.9% of this breakdownJapan: 246 citing papers, 1.9% of this breakdown
0%32.9%Other 23.4%

Fields

  • Medicine35.3%
  • Biochemistry, Genetics and Molecular Biology32.4%
  • Computer Science9.4%
  • Engineering7.9%
  • Immunology and Microbiology2.3%
  • Neuroscience2%
  • Other10.7%

Topics

  • RNA modifications and cancer5.2%
  • Cancer-related molecular mechanisms research3.1%
  • Cancer-related gene regulation2.6%
  • Acute Myeloid Leukemia Research2.2%
  • Lymphoma Diagnosis and Treatment2%
  • Epigenetics and DNA Methylation1.8%
  • Other83.1%

Coauthors

All papers

Open in search
  1. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chuan He, Jianjun Chen - Cell 2017 cited by 1,206

  2. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2016 cited by 1,620

  3. Dynamics analysis, synchronization and FPGA implementation of multiscroll Hopfield neural networks with non-polynomial memristor

    Authors: , , , , , , - Chaos Solitons & Fractals 2024 cited by 205

  4. A Novel Dynamic Hill Cipher and Its Applications on Medical IoT

    Authors: , , , , - IEEE Internet of Things Journal, IEEE Internet Things J. 2025 cited by 95

  5. A Robust Predefined-Time Convergence Zeroing Neural Network for Dynamic Matrix Inversion

    Authors: , , , , , - IEEE Transactions on Cybernetics, IEEE Trans. Cybern. 2022 cited by 105

  6. A Time-Varying Fuzzy Parameter Zeroing Neural Network for the Synchronization of Chaotic Systems

    Authors: , , , , - IEEE Transactions on Emerging Topics in Computational Intelligence, IEEE Trans. Emerg. Top. Comput. Intell. 2023 cited by 94

  7. Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,918

  8. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting

    Authors: , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2019 cited by 358

  9. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells

    Authors: , , , , , , , , , , - Drug Resistance Updates 2023 cited by 99

  10. A Predefined Fixed-Time Convergence ZNN and Its Applications to Time-Varying Quadratic Programming Solving and Dual-Arm Manipulator Cooperative Trajectory Tracking

    Authors: , , , , , , , - IEEE Transactions on Industrial Informatics, IEEE Trans. Ind. Informatics 2022 cited by 63

  11. A New-Type Zeroing Neural Network Model and Its Application in Dynamic Cryptography

    Authors: , , , , , - IEEE Transactions on Emerging Topics in Computational Intelligence, IEEE Trans. Emerg. Top. Comput. Intell. 2024 cited by 60

  12. ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 270

  13. A fixed-time convergent and noise-tolerant zeroing neural network for online solution of time-varying matrix inversion

    Authors: , , , - Applied Soft Computing, Appl. Soft Comput. 2022 cited by 65

  14. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qingshu Zeng, Zhihui Zhang, Zhen Cai, Xiequn Chen, Kaiyang Ding, Ming Hou, Huiqiang Huang, Xiaoling Li, Rong Liang, Qifa Liu, Yuqin Song, Hang Su, Yuhuan Gao, Lihong Liu, Jian‐Min Luo, Liping Su, Zimin Sun, Huo Tan, Huaqing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiaohong Zhang, Daobin Zhou, Ou Bai, Gang Wu, Liling Zhang, Yizhuo Zhang - Journal of Hematology & Oncology 2017 cited by 256

  15. A Complex-Valued Variant-Parameter Robust Zeroing Neural Network Model and its Applications

    Authors: , , , , , , , , , - IEEE Transactions on Emerging Topics in Computational Intelligence, IEEE Trans. Emerg. Top. Comput. Intell. 2024 cited by 53

  16. Dynamic analysis and hardware implementation of multi-scroll Hopfield neural networks with three different memristor synapses

    Authors: , , , , , , - Nonlinear Dynamics 2024 cited by 53

  17. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 cited by 307

  18. A new one-dimensional chaotic system with applications in image encryption

    Authors: , , - Chaos Solitons & Fractals 2020 cited by 112

  19. Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 169

  20. Novel activation functions-based ZNN models for fixed-time solving dynamirc Sylvester equation

    Authors: , , , - Neural Computing and Applications, Neural Comput. Appl. 2022 cited by 52

  21. Ultra-Reliable IoT Communications with UAVs: A Swarm Use Case

    Authors: , , , , - IEEE Communications Magazine, IEEE Commun. Mag. 2018 cited by 160

  22. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2022 cited by 107

  23. Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 75

  24. Research Advances on Matrine

    Authors: , , , , , , , , , , , , , , , , , - Frontiers in Chemistry 2022 cited by 89